Get started
Work

A clinical trial of intradermal and intramuscular seasonal influenza vaccination in patients with atopic dermatitis

Year: 2017
Type: article
DOI: 10.1016/j.jaci.2016.12.952
Authors: Donald Y.M. Leung, Brett Jepson, Lisa A. Beck, Jon M. Hanifin, Lynda C. Schneider, Amy S. Paller, Katherine Monti, Gloria David, Jennifer Canniff, Margarita Gomez Lorenzo, Adriana Weinberg
Institutions: National Jewish Health, Rho (United States), University of Rochester Medicine, University of Rochester, Oregon Health & Science University, Boston Children's Hospital, Northwestern University, University of Colorado Denver, National Institute of Allergy and Infectious Diseases
Language: English
Subfield: Epidemiology
Field: Medicine
Open Access status: bronze
Funders: GlaxoSmithKline, Sanofi, Celgene, Northwestern University, Array BioPharma, Harvard University, Harvard Catalyst, University of Rochester, Regeneron Pharmaceuticals, National Jewish Health, National Institutes of Health, Genentech, Feinberg School of Medicine, Medical Center, University of Rochester, University of Colorado Denver, Sanofi Pasteur, National Institute of Allergy and Infectious Diseases, National Center for Research Resources, National Center for Advancing Translational Sciences
Awards: G1092703474, G1114177658, G1160208864, G1470284823, G1616868727, G1792657809, Colorado Clinical and Translational Science Institute (UL1), G1978278092, G2661966628, G277117613, G3615943839, G475936976, G5699117591, G5962557371, G625104578, G6330574630, G6424384527, G7060033699, G7360236933, G7697517317, G7842410115, G7987750278, G9000033270, G9000046768, G9000060836, G9000089438, G9000211663, G9000233576, G9000307188, G9000351588, SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier
OpenAlex ID: W2588707751
FWCI: 0.927
Cites: 26
Cited by: 14
Related to: 10